New Urethral Reconstruction in Robot-assisted Laparoscopic Radical Resection - Trial NCT06355076
Access comprehensive clinical trial information for NCT06355076 through Pure Global AI's free database. This phase not specified trial is sponsored by Qilu Hospital of Shandong University and is currently Recruiting. The study focuses on Prostate Cancer. Target enrollment is 94 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Qilu Hospital of Shandong University
Timeline & Enrollment
N/A
Feb 05, 2023
Jun 01, 2026
Primary Outcome
Recovery of urinary incontinence
Summary
The purpose of this clinical trial is to compare new reconstruction and anastomosis in
 robot-assisted radical laparoscopic resection It will also understand the possibility of
 exploring new reconstruction in completely solving patients' postoperative urinary
 incontinence The main questions it aims to answer are:
 
 Is there a significant improvement in urinary control in patients with new reconstruction
 compared with patients with anastomosis? The researchers compared the new reconstruction with
 anastomosis in robot-assisted laparoscopic radical resection to see if the new reconstruction
 improved urinary incontinence after operation.
 
 Participants will:
 
 The intervention group adopted the new reconstruction proposed by our team; End-to-end
 anastomosis was performed in non-intervention group.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06355076
Non-Device Trial